EE+ POEM Archive
Ubrogepant modestly effective for acute migraine, but safety and a lack of comparison with triptans are concerning
Ubrogepant modestly effective for acute migraine, but safety and a lack of comparison with triptans are concerning is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Ubrogepant Modestly Effective for Acute Migraine, but Safety and a Lack of Comparison With Triptans Are Concerning." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314950/all/Ubrogepant_modestly_effective_for_acute_migraine__but_safety_and_a_lack_of_comparison_with_triptans_are_concerning.
Ubrogepant modestly effective for acute migraine, but safety and a lack of comparison with triptans are concerning. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314950/all/Ubrogepant_modestly_effective_for_acute_migraine__but_safety_and_a_lack_of_comparison_with_triptans_are_concerning. Accessed March 31, 2023.
Ubrogepant modestly effective for acute migraine, but safety and a lack of comparison with triptans are concerning. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314950/all/Ubrogepant_modestly_effective_for_acute_migraine__but_safety_and_a_lack_of_comparison_with_triptans_are_concerning
Ubrogepant Modestly Effective for Acute Migraine, but Safety and a Lack of Comparison With Triptans Are Concerning [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314950/all/Ubrogepant_modestly_effective_for_acute_migraine__but_safety_and_a_lack_of_comparison_with_triptans_are_concerning.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ubrogepant modestly effective for acute migraine, but safety and a lack of comparison with triptans are concerning
ID - 1314950
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314950/all/Ubrogepant_modestly_effective_for_acute_migraine__but_safety_and_a_lack_of_comparison_with_triptans_are_concerning
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
